Financhill
Sell
42

ECOR Quote, Financials, Valuation and Earnings

Last price:
$5.11
Seasonality move :
-6.12%
Day range:
$6.58 - $6.97
52-week range:
$5.02 - $19.49
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.02x
P/B ratio:
6.49x
Volume:
116.3K
Avg. volume:
124.3K
1-year change:
-2.99%
Market cap:
$49M
Revenue:
$25.2M
EPS (TTM):
-$1.62

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ECOR
electroCore
$6.9M -- 25.79% -- $25.20
APYX
Apyx Medical
$9.4M -$0.12 -8.35% -46.97% $4.00
ATEC
Alphatec Holdings
$168.2M -$0.12 22.9% -86.45% $18.21
KRMD
KORU Medical Systems
$8.9M -$0.03 8.12% -31.25% $5.70
NURO
NeuroMetrix
-- -- -- -- --
OWLT
Owlet
$18.1M -$0.24 22.98% -58.82% $10.17
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ECOR
electroCore
$6.81 $25.20 $49M -- $0.00 0% 2.02x
APYX
Apyx Medical
$1.25 $4.00 $47.2M -- $0.00 0% 0.92x
ATEC
Alphatec Holdings
$12.45 $18.21 $1.8B -- $0.00 0% 2.80x
KRMD
KORU Medical Systems
$2.72 $5.70 $125M -- $0.00 0% 3.70x
NURO
NeuroMetrix
$4.58 -- $9.4M -- $0.00 0% 2.97x
OWLT
Owlet
$4.15 $10.17 $68.7M -- $0.00 0% 0.59x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ECOR
electroCore
-- 1.885 -- 1.46x
APYX
Apyx Medical
70.46% 2.183 56.64% 4.40x
ATEC
Alphatec Holdings
118.58% 1.134 36.81% 1.54x
KRMD
KORU Medical Systems
1.59% 4.051 0.15% 2.16x
NURO
NeuroMetrix
-- 0.105 -- 12.38x
OWLT
Owlet
-228.59% 0.285 14.88% 0.89x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ECOR
electroCore
$6.1M -$3.1M -147.07% -147.07% -43.59% -$1.3M
APYX
Apyx Medical
$9M -$3M -45.86% -133.56% -20.51% -$3.2M
ATEC
Alphatec Holdings
$116M -$31.7M -31.36% -691.37% -26.09% -$16.7M
KRMD
KORU Medical Systems
$5.6M -$1.6M -32.31% -32.71% -17.98% $981.9K
NURO
NeuroMetrix
$312K -$1.7M -41.7% -41.7% -296.61% -$1.8M
OWLT
Owlet
$11M -$7.4M -- -- -37.31% $3.3M

electroCore vs. Competitors

  • Which has Higher Returns ECOR or APYX?

    Apyx Medical has a net margin of -45.81% compared to electroCore's net margin of -32.54%. electroCore's return on equity of -147.07% beat Apyx Medical's return on equity of -133.56%.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    85.89% -$0.40 $7.5M
    APYX
    Apyx Medical
    63.03% -$0.12 $48.2M
  • What do Analysts Say About ECOR or APYX?

    electroCore has a consensus price target of $25.20, signalling upside risk potential of 270.04%. On the other hand Apyx Medical has an analysts' consensus of $4.00 which suggests that it could grow by 220%. Given that electroCore has higher upside potential than Apyx Medical, analysts believe electroCore is more attractive than Apyx Medical.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    APYX
    Apyx Medical
    1 2 0
  • Is ECOR or APYX More Risky?

    electroCore has a beta of 0.916, which suggesting that the stock is 8.354% less volatile than S&P 500. In comparison Apyx Medical has a beta of 1.117, suggesting its more volatile than the S&P 500 by 11.729%.

  • Which is a Better Dividend Stock ECOR or APYX?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Apyx Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. Apyx Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or APYX?

    electroCore quarterly revenues are $7M, which are smaller than Apyx Medical quarterly revenues of $14.2M. electroCore's net income of -$3.2M is higher than Apyx Medical's net income of -$4.6M. Notably, electroCore's price-to-earnings ratio is -- while Apyx Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 2.02x versus 0.92x for Apyx Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    2.02x -- $7M -$3.2M
    APYX
    Apyx Medical
    0.92x -- $14.2M -$4.6M
  • Which has Higher Returns ECOR or ATEC?

    Alphatec Holdings has a net margin of -45.81% compared to electroCore's net margin of -30.68%. electroCore's return on equity of -147.07% beat Alphatec Holdings's return on equity of -691.37%.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    85.89% -$0.40 $7.5M
    ATEC
    Alphatec Holdings
    68.56% -$0.35 $462.5M
  • What do Analysts Say About ECOR or ATEC?

    electroCore has a consensus price target of $25.20, signalling upside risk potential of 270.04%. On the other hand Alphatec Holdings has an analysts' consensus of $18.21 which suggests that it could grow by 46.25%. Given that electroCore has higher upside potential than Alphatec Holdings, analysts believe electroCore is more attractive than Alphatec Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    ATEC
    Alphatec Holdings
    6 1 0
  • Is ECOR or ATEC More Risky?

    electroCore has a beta of 0.916, which suggesting that the stock is 8.354% less volatile than S&P 500. In comparison Alphatec Holdings has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.249%.

  • Which is a Better Dividend Stock ECOR or ATEC?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. Alphatec Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or ATEC?

    electroCore quarterly revenues are $7M, which are smaller than Alphatec Holdings quarterly revenues of $169.2M. electroCore's net income of -$3.2M is higher than Alphatec Holdings's net income of -$51.9M. Notably, electroCore's price-to-earnings ratio is -- while Alphatec Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 2.02x versus 2.80x for Alphatec Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    2.02x -- $7M -$3.2M
    ATEC
    Alphatec Holdings
    2.80x -- $169.2M -$51.9M
  • Which has Higher Returns ECOR or KRMD?

    KORU Medical Systems has a net margin of -45.81% compared to electroCore's net margin of -17.66%. electroCore's return on equity of -147.07% beat KORU Medical Systems's return on equity of -32.71%.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    85.89% -$0.40 $7.5M
    KRMD
    KORU Medical Systems
    62.94% -$0.03 $17.1M
  • What do Analysts Say About ECOR or KRMD?

    electroCore has a consensus price target of $25.20, signalling upside risk potential of 270.04%. On the other hand KORU Medical Systems has an analysts' consensus of $5.70 which suggests that it could grow by 109.56%. Given that electroCore has higher upside potential than KORU Medical Systems, analysts believe electroCore is more attractive than KORU Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    KRMD
    KORU Medical Systems
    4 1 0
  • Is ECOR or KRMD More Risky?

    electroCore has a beta of 0.916, which suggesting that the stock is 8.354% less volatile than S&P 500. In comparison KORU Medical Systems has a beta of 0.392, suggesting its less volatile than the S&P 500 by 60.809%.

  • Which is a Better Dividend Stock ECOR or KRMD?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. KORU Medical Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. KORU Medical Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or KRMD?

    electroCore quarterly revenues are $7M, which are smaller than KORU Medical Systems quarterly revenues of $8.8M. electroCore's net income of -$3.2M is lower than KORU Medical Systems's net income of -$1.6M. Notably, electroCore's price-to-earnings ratio is -- while KORU Medical Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 2.02x versus 3.70x for KORU Medical Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    2.02x -- $7M -$3.2M
    KRMD
    KORU Medical Systems
    3.70x -- $8.8M -$1.6M
  • Which has Higher Returns ECOR or NURO?

    NeuroMetrix has a net margin of -45.81% compared to electroCore's net margin of -256.8%. electroCore's return on equity of -147.07% beat NeuroMetrix's return on equity of -41.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    85.89% -$0.40 $7.5M
    NURO
    NeuroMetrix
    53.12% -$0.75 $16M
  • What do Analysts Say About ECOR or NURO?

    electroCore has a consensus price target of $25.20, signalling upside risk potential of 270.04%. On the other hand NeuroMetrix has an analysts' consensus of -- which suggests that it could grow by 8633.63%. Given that NeuroMetrix has higher upside potential than electroCore, analysts believe NeuroMetrix is more attractive than electroCore.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    NURO
    NeuroMetrix
    0 0 0
  • Is ECOR or NURO More Risky?

    electroCore has a beta of 0.916, which suggesting that the stock is 8.354% less volatile than S&P 500. In comparison NeuroMetrix has a beta of 1.001, suggesting its more volatile than the S&P 500 by 0.075000000000003%.

  • Which is a Better Dividend Stock ECOR or NURO?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroMetrix offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. NeuroMetrix pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or NURO?

    electroCore quarterly revenues are $7M, which are larger than NeuroMetrix quarterly revenues of $587.3K. electroCore's net income of -$3.2M is lower than NeuroMetrix's net income of -$1.5M. Notably, electroCore's price-to-earnings ratio is -- while NeuroMetrix's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 2.02x versus 2.97x for NeuroMetrix. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    2.02x -- $7M -$3.2M
    NURO
    NeuroMetrix
    2.97x -- $587.3K -$1.5M
  • Which has Higher Returns ECOR or OWLT?

    Owlet has a net margin of -45.81% compared to electroCore's net margin of -44.19%. electroCore's return on equity of -147.07% beat Owlet's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    85.89% -$0.40 $7.5M
    OWLT
    Owlet
    53.52% -$0.63 -$5.1M
  • What do Analysts Say About ECOR or OWLT?

    electroCore has a consensus price target of $25.20, signalling upside risk potential of 270.04%. On the other hand Owlet has an analysts' consensus of $10.17 which suggests that it could grow by 145.28%. Given that electroCore has higher upside potential than Owlet, analysts believe electroCore is more attractive than Owlet.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    OWLT
    Owlet
    3 0 0
  • Is ECOR or OWLT More Risky?

    electroCore has a beta of 0.916, which suggesting that the stock is 8.354% less volatile than S&P 500. In comparison Owlet has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock ECOR or OWLT?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Owlet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. Owlet pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or OWLT?

    electroCore quarterly revenues are $7M, which are smaller than Owlet quarterly revenues of $20.5M. electroCore's net income of -$3.2M is higher than Owlet's net income of -$9.1M. Notably, electroCore's price-to-earnings ratio is -- while Owlet's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 2.02x versus 0.59x for Owlet. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    2.02x -- $7M -$3.2M
    OWLT
    Owlet
    0.59x -- $20.5M -$9.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Is BYD a Threat To Tesla Shareholders?
Is BYD a Threat To Tesla Shareholders?

BYD (OTC:BYDDY) has rocketed to the top of China’s booming…

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 8

Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.

Buy
92
TPB alert for May 8

Turning Point Brands [TPB] is down 6.67% over the past day.

Buy
74
LIVN alert for May 8

LivaNova PLC [LIVN] is up 1.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock